首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1454140

紫杉醇注射液市場，按適應症類型、按應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Paclitaxel Injection Market, By Indication Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年03月04日 | 出版商:

AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

報告要點

2023年紫杉醇注射劑市場規模為61,0452萬美元，2024年至2032年複合CAGR為12.90%。

紫杉醇注射液市場-市場動態

癌症患者數量的增加預計將推動市場成長

隨著癌症病例數持續增加，癌症構成了一個重大的全球健康問題。各種因素，包括人口老化、生活方式的改變、環境影響以及癌症檢測和診斷的進步，都在全球癌症盛行率上升的過程中發揮了作用。根據美國國家衛生統計中心預計，2023年，美國將新增癌症病例1,958,310例，癌症相關死亡病例將達609,820例。此外，由於醫療保健基礎設施的改善，特別是在發展中經濟體，紫杉醇注射液市場的成長預計將擴大。然而，監管方面的挑戰可能會阻礙市場的成長。

紫杉醇注射液市場-關鍵洞察

根據研究分析師的分析，預計全球市場在預測期內（2024-2032）每年將以 12.90%左右的CAGR成長

根據適應症類型細分，預計乳癌將在2023年顯示出最大的市場佔有率

從應用細分來看，2023年醫院為主導類型

依地區分類，北美是2023年的主要收入來源

紫杉醇注射液市場-細分分析：

全球紫杉醇注射液市場根據適應症類型、應用和地區進行細分。

依適應症類型，市場分為十一類：攝護腺癌、乳癌、非小細胞肺癌、愛滋病相關的卡波西氏肉瘤、卵巢癌、胃癌、子宮頸癌、食道癌、睪丸癌、肺癌、胰臟癌癌症和其他。乳癌在市場上佔有最大佔有率。紫杉醇是一種廣泛認可且常用的治療乳癌的化療藥物。它是主要癌症治療指南推薦的各種乳癌亞型（包括早期和轉移性疾病）的標準治療方案的一部分。

市場根據應用分為三個部分：癌症研究中心、醫院和其他。市場的成長主要由醫院部門推動。醫院在向患者提供化療和其他癌症治療方面發揮關鍵作用，其中包括將紫杉醇作為不同類型癌症（例如乳腺癌）的標準治療方法。

紫杉醇注射液市場-地理洞察

從地理上看，該市場橫跨北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據對商業活動有貢獻的國家進一步細分。在標靶治療需求不斷成長的推動下，亞太地區預計將引領市場成長。標靶治療致力於癌細胞，同時最大限度地減少對健康組織的傷害，在亞太地區越來越受歡迎。紫杉醇與標靶藥物結合或用於精準醫療方法時，可以增強這些療法的有效性，促進市場擴張。光是在中國，就有 30 個適應症的20 個藥物（25.6%）獲得批准，其中 14 個（70.0%）是在2017年之後獲得批准的；根據美國醫學會的預測，20 例中有 15 例（75.0%）是標靶療法，20 例中有 4 例（20.0%）是免疫療法。展望未來，由於醫療基礎設施投資和支出增加，歐洲預計在來年成為第二大市場成長地區。

紫杉醇注射液市場-競爭格局：

紫杉醇注射液供應商之間的競爭受到監管、經濟、技術和商業因素的多方面綜合影響。為了在不斷變化的醫療保健產業中建立競爭優勢，製造商需要策略性地駕馭這些動態。紫杉醇注射液市場的競爭差異化是由創新和研發投資所驅動的。製造商有機會開發新的配方、輸送技術或聯合療法，以增強治療效果、提高患者便利性並最大限度地減少治療相關的副作用。

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美紫杉醇注射液主要生產商
- 北美市場規模和預測（依國家）
- 北美市場規模與預測（按適應症類型）
- 北美市場規模和預測（依應用）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲紫杉醇注射液主要製造商
- 歐洲市場規模和預測（依國家）
- 歐洲市場規模和預測（按適應症類型）
- 歐洲市場規模和預測（依應用）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區（APAC）
- 概述
- 亞太地區紫杉醇注射液主要生產商
- 亞太地區市場規模與預測（依國家）
- 亞太地區市場規模與預測（依適應症類型）
- 亞太地區市場規模與預測（依應用）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲紫杉醇注射液主要製造商
- 拉丁美洲市場規模與預測（依國家）
- 拉丁美洲市場規模與預測（按適應症類型）
- 拉丁美洲市場規模與預測（依應用）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲紫杉醇注射劑主要生產商
- 中東和非洲市場規模及預測（依國家）
- 中東和非洲市場規模及預測（按適應症類型）
- 中東和非洲市場規模及預測（依應用）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA的其他地區

第10章主要供應商分析-紫杉醇注射液產業

競爭儀表板
公司簡介
- Pfizer
- Celgene Corporation
- Fresenius Kabi Oncology Ltd
- Abbott Laboratories
- Onco Therapies Ltd（Strides Arcolab Ltd.）
- Sagent Pharmaceuticals
- Bristol Myers Squibb
- Luye Pharma Group
- NOVASEP
- Others

第11章 360 度分析師視角

第12章附錄

研究方法論
參考
縮寫
免責聲明
聯絡我們

簡介目錄圖表

Product Code: ANV2321

REPORT HIGHLIGHT

Paclitaxel Injection Market size was valued at USD 6,104.52 Million in 2023, expanding at a CAGR of 12.90% from 2024 to 2032.

Paclitaxel is a chemotherapy medication designed to combat cancer by attacking fast-growing cancer cells. It is administered via injection and is typically prescribed for late-stage ovarian, breast, non-small cell lung cancer, and Kaposi sarcoma. Kaposi sarcoma, a type of cancer that impacts the skin and mucous membranes, is frequently diagnosed in individuals with AIDS. It is crucial that Paclitaxel (formulated with polyoxyethylated castor oil) injections are administered by a skilled oncologist in a hospital or medical setting.

Paclitaxel Injection Market- Market Dynamics

The rise in the number of cancer patients is expected to propel the market growth

Cancer poses a major worldwide health issue, as the number of cancer cases continues to increase. Various factors, including aging populations, lifestyle modifications, environmental influences, and advancements in cancer detection and diagnosis, all play a role in the rising prevalence of cancer globally. According to the National Center for Health Statistics, it is estimated that in 2023, there will be 1,958,310 new cases of cancer and 609,820 cancer-related deaths in the United States. Additionally, the growth of the paclitaxel injection market is expected to expand due to the improvement of healthcare infrastructure, especially in developing economies. Nevertheless, challenges in regulations may impede the market's growth.

Paclitaxel Injection Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.90% over the forecast period (2024-2032)

Based on Indication Type segmentation, Breast Cancer was predicted to show maximum market share in the year 2023

Based on application segmentation, Hospitals was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Paclitaxel Injection Market- Segmentation Analysis:

The Global Paclitaxel Injection Market is segmented on the basis of Indication Type, Application, and Region.

The market is segmented into eleven categories according to Indication Type: Prostate Cancer, Breast Cancer, Non-small Cell Lung Cancer, AIDS-related Kaposi's sarcoma, Ovarian Cancer, Stomach Cancer, Cervical Cancer, Esophageal Cancer, Testicular Cancer, Lung Cancer, Pancreatic Cancer, and Others. Breast Cancer holds the largest share in the market. Paclitaxel is a widely recognized and commonly used chemotherapy medication for treating breast cancer. It is part of the standard treatment regimens recommended by major cancer treatment guidelines for various subtypes of breast cancer, including early-stage and metastatic disease.

The market is categorized into three segments according to their application: Cancer Research Centers, Hospitals, and Others. The growth of the market is primarily driven by the hospital sector. Hospitals play a pivotal role in delivering chemotherapy and other cancer treatments to patients, which includes the administration of paclitaxel as a standard treatment for different types of cancer, such as breast cancer.

Paclitaxel Injection Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The Asia Pacific region is expected to lead the market growth, driven by the increasing demand for targeted therapies. Targeted therapies, which focus on cancer cells while minimizing harm to healthy tissues, are gaining popularity in the Asia Pacific region. Paclitaxel, when combined with targeted agents or used in precision medicine approaches, enhances the effectiveness of these therapies, thus boosting market expansion. In China alone, twenty drugs (25.6%) for 30 indications were approved, with 14 (70.0%) of them authorized after 2017; 15 out of 20 (75.0%) were targeted therapies, and 4 out of 20 (20.0%) were immunotherapies, as projected by the American Medical Association. Looking ahead, Europe is poised to become the second largest region for market growth in the upcoming year, thanks to increased investments in healthcare infrastructure and expenditures.

Paclitaxel Injection Market- Competitive Landscape:

The competition among suppliers of paclitaxel injection is influenced by a multifaceted combination of regulatory, economic, technological, and commercial factors. To establish a competitive edge in the ever-changing healthcare industry, manufacturers need to strategically navigate these dynamics. Competitive differentiation within the paclitaxel injection market is driven by innovation and investment in research and development. Manufacturers have the opportunity to develop new formulations, delivery technologies, or combination therapies that can enhance therapeutic outcomes, improve patient convenience, and minimize treatment-related side effects.

Recent Developments:

Pfizer has revealed the introduction of three new biosimilars, namely ZIRABEV (bevacizumab-bvzr), RUXIENCE (rituximab-pvvr), and TRAZIMERA (trastuzumab-qyyp) in the United States (U.S.). These medications are anticipated to be released at the most competitive Wholesale Acquisition Cost (WAC) compared to other bevacizumab, rituximab, or trastuzumab products currently in the market, offering a significantly reduced price compared to the original product.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PACLITAXEL INJECTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer

Celgene Corporation

Fresenius Kabi Oncology Ltd

Abbott Laboratories

Onco Therapies Ltd (Strides Arcolab Ltd.)

Sagent Pharmaceuticals

Bristol Myers Squibb

Luye Pharma Group

NOVASEP

Others

GLOBAL PACLITAXEL INJECTION MARKET, BY INDICATION TYPE- MARKET ANALYSIS, 2019 - 2032

Prostate Cancer
Breast Cancer
Non-small Cell Lung Cancer
AIDS-related Kaposi's Sarcoma
Ovarian Cancer
Stomach Cancer
Cervical Cancer
Esophageal Cancer
Testicular Cancer
Lung Cancer
Pancreatic Cancer
Others

GLOBAL PACLITAXEL INJECTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cancer Research Centers
Hospital
Others

GLOBAL PACLITAXEL INJECTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Paclitaxel Injection Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Paclitaxel Injection Market Snippet by Indication Type
- 2.1.2.Paclitaxel Injection Market Snippet by Application
- 2.1.3.Paclitaxel Injection Market Snippet by Country
- 2.1.4.Paclitaxel Injection Market Snippet by Region
2.2.Competitive Insights

3.Paclitaxel Injection Key Market Trends

3.1.Paclitaxel Injection Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Paclitaxel Injection Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Paclitaxel Injection Market Opportunities
3.4.Paclitaxel Injection Market Future Trends

4.Paclitaxel Injection Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Paclitaxel Injection Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Paclitaxel Injection Market Landscape

6.1.Paclitaxel Injection Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Paclitaxel Injection Market - By Indication Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Indication Type, 2023 & 2032 (%)
- 7.1.2.Prostate Cancer
- 7.1.3.Breast Cancer
- 7.1.4.Non-small Cell Lung Cancer
- 7.1.5.AIDS-related Kaposi's Sarcoma
- 7.1.6.Ovarian Cancer
- 7.1.7.Stomach Cancer
- 7.1.8.Cervical Cancer
- 7.1.9.Esophageal Cancer
- 7.1.10.Testicular Cancer
- 7.1.11.Lung Cancer
- 7.1.12.Pancreatic Cancer
- 7.1.13.Others

8.Paclitaxel Injection Market - By Application

8.1.Overview
- 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2.Cancer Research Centers
- 8.1.3.Hospital
- 8.1.4.Others

9.Paclitaxel Injection Market- By Geography

9.1.Introduction
- 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2.North America
- 9.2.1.Overview
- 9.2.2.Paclitaxel Injection Key Manufacturers in North America
- 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4.North America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.2.6.U.S.
  - 9.2.6.1.Overview
  - 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3.U.S. Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.2.7.Canada
  - 9.2.7.1.Overview
  - 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3.Canada Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.3.Europe
- 9.3.1.Overview
- 9.3.2.Paclitaxel Injection Key Manufacturers in Europe
- 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4.Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.6.Germany
  - 9.3.6.1.Overview
  - 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3.Germany Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.7.Italy
  - 9.3.7.1.Overview
  - 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3.Italy Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.8.United Kingdom
  - 9.3.8.1.Overview
  - 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3.United Kingdom Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.9.France
  - 9.3.9.1.Overview
  - 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3.France Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.10.Russia
  - 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.2.Russia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.11.Netherlands
  - 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2.Netherlands Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.12.Sweden
  - 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2.Sweden Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.13.Poland
  - 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2.Poland Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.3.14.Rest of Europe
  - 9.3.14.1.Overview
  - 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.3.Rest of the Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.4.Asia Pacific (APAC)
- 9.4.1.Overview
- 9.4.2.Paclitaxel Injection Key Manufacturers in Asia Pacific
- 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4.Asia Pacific Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.6.India
  - 9.4.6.1.Overview
  - 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3.India Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.7.China
  - 9.4.7.1.Overview
  - 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3.China Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.8.Japan
  - 9.4.8.1.Overview
  - 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3.Japan Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.9.South Korea
  - 9.4.9.1.Overview
  - 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3.South Korea Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.10.Australia
  - 9.4.10.1.Overview
  - 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3.Australia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.11.Thailand
  - 9.4.11.1.Overview
  - 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3.Thailand Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.12.Indonesia
  - 9.4.12.1.Overview
  - 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3.Indonesia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.13.Philippines
  - 9.4.13.1.Overview
  - 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3.Philippines Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.4.14.Rest of APAC
  - 9.4.14.1.Overview
  - 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3.Rest of APAC Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.5.Latin America
- 9.5.1.Overview
- 9.5.2.Paclitaxel Injection Key Manufacturers in Latin America
- 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4.Latin America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.6.Brazil
  - 9.5.6.1.Overview
  - 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3.Brazil Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.7.Mexico
  - 9.5.7.1.Overview
  - 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3.Mexico Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.8.Argentina
  - 9.5.8.1.Overview
  - 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3.Argentina Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.9.Colombia
  - 9.5.9.1.Overview
  - 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3.Colombia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.5.10.Rest of LATAM
  - 9.5.10.1.Overview
  - 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3.Rest of LATAM Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
9.6.Middle East and Africa
- 9.6.1.Overview
- 9.6.2.Paclitaxel Injection Key Manufacturers in Middle East and Africa
- 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4.Middle East and Africa Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.6.Saudi Arabia
  - 9.6.6.1.Overview
  - 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3.Saudi Arabia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.7.United Arab Emirates
  - 9.6.7.1.Overview
  - 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3.United Arab Emirates Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.8.Israel
  - 9.6.8.1.Overview
  - 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3.Israel Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.9.Turkey
  - 9.6.9.1.Overview
  - 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3.Turkey Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.10.Algeria
  - 9.6.10.1.Overview
  - 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3.Algeria Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.11.Egypt
  - 9.6.11.1.Overview
  - 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3.Egypt Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 9.6.12.Rest of MEA
  - 9.6.12.1.Overview
  - 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3.Rest of MEA Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  - 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Paclitaxel Injection Industry

10.1.Competitive Dashboard
10.2.Company Profiles
- 10.2.1.Pfizer
- 10.2.2.Celgene Corporation
- 10.2.3.Fresenius Kabi Oncology Ltd
- 10.2.4.Abbott Laboratories
- 10.2.5.Onco Therapies Ltd (Strides Arcolab Ltd.)
- 10.2.6.Sagent Pharmaceuticals
- 10.2.7.Bristol Myers Squibb
- 10.2.8.Luye Pharma Group
- 10.2.9.NOVASEP
- 10.2.10.Others

11.360 Degree Analyst View

12.Appendix

12.1.Research Methodology
12.2.References
12.3.Abbreviations
12.4.Disclaimer
12.5.Contact Us

簡介目錄圖表

List of Tables

TABLE List of data Indication Types
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Paclitaxel Injection Market: Indication Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Indication Type
TABLE Global Paclitaxel Injection Market, by Indication Type 2019-2032 (USD Million)
TABLE Paclitaxel Injection Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Paclitaxel Injection Market, by Application 2019-2032 (USD Million)
TABLE Paclitaxel Injection Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Paclitaxel Injection Market, by Region 2019-2032 (USD Million)
TABLE North America Paclitaxel Injection Market, by Country, 2019-2032 (USD Million)
TABLE North America Paclitaxel Injection Market, by Indication Type, 2019-2032 (USD Million)
TABLE North America Paclitaxel Injection Market, by Application, 2019-2032 (USD Million)
TABLE Europe Paclitaxel Injection Market, by Country, 2019-2032 (USD Million)
TABLE Europe Paclitaxel Injection Market, by Indication Type, 2019-2032 (USD Million)
TABLE Europe Paclitaxel Injection Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Paclitaxel Injection Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Paclitaxel Injection Market, by Indication Type, 2019-2032 (USD Million)
TABLE Asia Pacific Paclitaxel Injection Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Paclitaxel Injection Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Paclitaxel Injection Market, by Indication Type, 2019-2032 (USD Million)
TABLE Latin America Paclitaxel Injection Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Paclitaxel Injection Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Paclitaxel Injection Market, by Indication Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Paclitaxel Injection Market, by Application, 2019-2032 (USD Million)